Danaher Corporation vs Pfizer, Inc. — Stock Comparison

DHR
Danaher Corporation
$175.15
▼ 2.12%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Danaher Corporation
DHR7.7/10vs 6.5/10

Q·Score Breakdown

7.7
Bullish
Overall
6.5
Neutral
6.7
Quality
7.4
9.1
Health
7
6.2
Growth
5.6
8.6
Valuation
6.7
8.6
Sentiment
5.2
DHR

Clean balance sheet with low leverage (0.4× debt-to-equity).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
Target $250.14 (+42.8%)
22 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

DHR
PFE
33.9×
Trailing P/E
19.4×
19.3×
Forward P/E
9.4×
14.9%
Profit Margin
12.4%
59.0%
Gross Margin
75.8%
7.1%
ROE
8.9%
3.7%
Revenue Growth
-1.2%
9.8%
Earnings Growth
0.99
Beta
0.39
Price / Book
$124.0B
Market Cap
$149.8B
$175 – $243
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →